IMO, David and management have done an excellent job developing Anteotech from a research company to one at the early stages of achieving commercialisation deals.
they have developed the partnerships in CET
View attachment 6514521expanded the potential market size with AnteoX, Ultranode and newly formed advanced chemistries
also in Life science
new product anteobindNXT
SIOI commercial deal
vidcare with the backing of the Indian "health for all" initiative
fisheries POC
burnet institute liver test
they have built the initial 20K litre production facility, setting up an automated anteobind line and anode production
the newly advertised positions of 3 production jobs, VP sales and marketing communication position fills voids and suggests commercialisation is close.
so any voting from me will be to maintain the status quo at the AGM.
but David only has just over 7 weeks to make some announcements before he would get my vote for any performance package.
as I posted above the team has done a good job (IMO) but they did sign off the last raise. maybe it was the only way they could have raised the money, we will never know, but it's undeniable that it has been the major reason that has sucked all goodwill and confidence from the market towards anteotech.
I'll vote yes to any performance package, as long as shareholders are taken along with it. but not with the sp sitting at 2c.
but he has 7 weeks to go. show the market how funding from the tax rebate till the option conversion next year will be covered (to stop another raise). give us a detailed quarterly with both technical advancements, increased revenue and partnership developments. and give us another commercial deal or JV partnership that has been hinted at over the last 6 mths.
was the agm date a couple weeks later this year to allow for progress to be announced or will the AGM be a little hostile?
"tick tock"
GLTAH.......
